Header Logo

Connection

Joydip Das to Molecular Targeted Therapy

Back to Details
This is a "connection" page, showing publications Joydip Das has written about Molecular Targeted Therapy.
Joydip Das
Connection Strength
0.126
Molecular Targeted Therapy
  1. Novel N-pyrimidin-4-yl-3-amino-pyrrolo [3, 4-C] pyrazole derivatives as PKC kinase inhibitors: a patent evaluation of US2015099743 (A1). Expert Opin Ther Pat. 2016; 26(4):523-8.
    View in: PubMed
    Score: 0.126
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.